Frank A. D'Amelio, the seasoned corporate executive best known for his long tenure as CFO of Pfizer and his current board-level work at Hewlett Packard Enterprise, has an estimated net worth of around $9 million as of mid-2026. Readers asking about Frank Amedia net worth will likely find it helpful to understand how this estimate is grounded in SEC filings and executive compensation disclosures. That figure comes primarily from publicly traceable equity holdings, executive compensation disclosures, and insider transaction filings rather than celebrity guesswork, which makes it one of the more verifiable estimates you'll find for any 'Frank' in this database. Frank Azor net worth or Frank Addante net worth can be different case studies within the same corporate-executive lane.
Frank D’Amelio Net Worth: Estimate, Sources, and Evidence Checklist
Who Frank D'Amelio is (and why you're searching this)
Before diving into the numbers, a quick disambiguation is worth your time. Wikipedia flags 'Frank D'Amelio' as a name shared by more than one notable person, so if you landed here looking for someone connected to TikTok fame or entertainment, you may be thinking of a different individual. The Frank D'Amelio this article covers is Frank A. If you're specifically asking for Frank Amodeo net worth, note that this article focuses on Frank A. If you are also comparing adjacent corporate-executive profiles, you may want to check frank amodeo net worth for a broader sense of how these compensation patterns translate into different results If you're specifically asking for Frank Amodeo net worth. D'Amelio, so the figures may not match what you expect <a data-article-id="467C036F-0AEE-4986-A2A3-B7C091D3441A">Frank A. D'Amelio</a>. D'Amelio, a career finance executive who spent nearly 14 years as Chief Financial Officer at Pfizer, one of the largest pharmaceutical companies in the world. He later moved into board and advisory roles, including a directorship at Hewlett Packard Enterprise (HPE). His wealth story is a straightforward one: decades of high-level corporate compensation, equity accumulation, and smart positioning in the boardroom rather than viral moments or brand deals. That's actually what makes it interesting to document, because the paper trail is unusually clear.
Current estimated net worth: the direct answer
The most credible current estimate puts Frank A. D'Amelio's net worth at approximately $9 million, with a reasonable range of $7 million to $12 million. The lower bound reflects conservative valuation of his disclosed equity positions minus reasonable tax and liquidity assumptions. The upper bound accounts for private assets, retirement accounts, and any compensation not fully captured in public filings. MarketScreener published a valuation figure of exactly $9 million as of April 29, 2026, and that aligns well with what you can independently piece together from SEC filings. This is not a billionaire's portfolio, but it is a solidly documented, upper-professional-class fortune built over a multi-decade executive career.
How this estimate is calculated
Net worth estimates for corporate executives are more transparent than for entertainers or athletes, because public companies are legally required to disclose insider ownership. Here is what the estimate for Frank D'Amelio is actually based on, and how confident you should be in each piece.
| Data Source | What It Shows | Confidence Level |
|---|---|---|
| SEC Form 4 filings (via SEC.gov) | Equity transactions, RSU grants, shares owned | High — legally required disclosures |
| Proxy statements (DEF 14A) | Annual compensation, bonus, equity awards | High — audited public filings |
| MarketScreener valuation | $9M estimate as of April 29, 2026 | Medium — aggregates public data, methodology not fully published |
| Public property records | Real estate holdings | Medium — publicly searchable but may be incomplete |
| Retirement and private accounts | 401(k), IRAs, private investments | Low — not publicly disclosed |
The strongest evidence comes from SEC filings. As recently as May 1, 2026, a Form 4 filed with the SEC shows D'Amelio received 8,750 restricted stock units (RSUs) from HPE on a cliff vesting schedule. That kind of filing is a direct window into ongoing equity compensation that keeps updating his wealth position. The weakest part of any estimate like this is everything that isn't required to be disclosed: savings accounts, private investments, and real estate held in ways that don't surface in public records.
Where the money comes from: key income sources
Frank D'Amelio's wealth has a few distinct pillars, each contributing at different stages of his career.
- Pfizer CFO compensation (roughly 2007 to 2021): As CFO of a Fortune 500 pharma giant, D'Amelio would have earned base salaries likely in the $1.5 million to $2 million range annually, plus bonuses and equity awards. Over nearly 14 years, this represents the core engine of his wealth accumulation.
- Equity awards and vested stock: Long-tenured executives at companies like Pfizer accumulate significant equity over time. Vested RSUs and stock options, especially during years when Pfizer's stock performed well (including the COVID vaccine period), would have materially boosted his net worth.
- Board director fees (HPE and others): Board memberships at public companies typically pay $200,000 to $400,000 per year in cash and stock. D'Amelio's HPE directorship, evidenced by the May 2026 RSU grant, is an ongoing income stream.
- Investment returns: A $9 million portfolio, even conservatively managed, generates meaningful passive income. Executives at this level typically hold diversified investment accounts built up over decades.
- Advisory and consulting roles: Post-CFO executives often take paid advisory positions. While specific engagements for D'Amelio are not publicly documented, this is a common wealth driver for people at his career stage.
Wealth timeline: how the number likely changed over time
D'Amelio's financial trajectory follows a recognizable arc for long-tenured Fortune 500 executives. In the early years of his Pfizer CFO role (post-2007), his net worth was likely in the low single-digit millions, growing steadily through salary and initial equity vesting. By the mid-2010s, accumulated equity and investment compounding would have pushed that figure higher, probably into the $4 million to $6 million range. The most significant wealth event was almost certainly the 2020 to 2021 period, when Pfizer's stock surged dramatically on the back of the COVID-19 vaccine rollout. Any unvested equity that matured during that window would have appreciated substantially. His transition off the CFO role and into board work reduced the rate of new compensation accumulation, but the existing portfolio continued to grow. The $9 million estimate in April 2026 represents a mature, relatively stable wealth position rather than a rapidly climbing one.
How to verify this estimate yourself
If you want to check or update this figure on your own, here is a practical checklist of exactly where to look and what to look for.
- Search SEC EDGAR (sec.gov/cgi-bin/browse-edgar) for 'DAMELIO FRANK A' to pull all Form 4 filings. These show every disclosed equity transaction including RSU grants, open market purchases, and sales.
- Pull the most recent HPE proxy statement (DEF 14A filing on EDGAR) to see director compensation tables, which will show cash fees and equity grants for the current year.
- Check MarketScreener's profile for Frank D'Amelio to see their aggregated estimate and the date it was last updated (their April 29, 2026 figure is the most recent publicly available).
- Search county property records in areas where D'Amelio is known to have lived (New Jersey and New York are the most likely) for real estate holdings.
- Look up any recent Pfizer proxy statements from his final years as CFO (2019 to 2021) to see his total compensation packages, which will give you a concrete earnings baseline.
- Cross-reference any news coverage of Pfizer stock performance during 2020 to 2021 with the vesting schedules disclosed in those earlier proxy statements to estimate what his equity was worth at peak.
What could push the number up or down from here
No net worth estimate is static, and a few realistic factors could meaningfully shift D'Amelio's figure in either direction over the next few years.
| Factor | Direction | Likely Impact |
|---|---|---|
| HPE stock price appreciation | Upside | Medium: RSU value rises with share price |
| Additional board appointments | Upside | Medium: each new public board adds $200K-$400K/year |
| HPE stock decline | Downside | Medium: unvested RSUs lose value |
| Sale of real estate at a loss | Downside | Low to medium depending on holdings |
| Market downturn affecting investment portfolio | Downside | Medium: $9M portfolio is exposed to equity markets |
| Undisclosed private investments performing well | Upside | Low confidence — not publicly traceable |
The most actionable upside scenario is straightforward: if D'Amelio adds another board seat or two, which is common for executives of his caliber, the annual equity and cash flow from those positions could push his net worth past $12 million within a few years. The downside scenario most worth watching is simply equity market performance, since a portfolio at this size is meaningfully exposed to the broader market. There is no obvious financial distress indicator or liability that would suggest a sudden drop.
Putting it in context
Compared to other Franks documented in this database, D'Amelio's $9 million estimate sits in a middle tier: well above many entertainers and minor public figures, but far below the self-made tech founders and major entertainment names. What distinguishes his case is the quality of the evidence. Unlike figures whose net worth relies heavily on estimated brand valuations or unverified social media earnings, D'Amelio's wealth is largely grounded in SEC-filed data. That makes the estimate more reliable, even if it is less flashy. If you are researching corporate executive wealth as a category, his profile sits alongside figures like Frank Addante and Frank Azor, who also built their wealth through institutional business roles rather than entertainment. If you meant Frank Azor net worth instead, you can follow the same approach by checking filings and credible third-party valuations for that specific person. You may also see similar methodologies applied to estimates like Frank Addante net worth, which rely on disclosed earnings, holdings, and filings. The methods for researching all of them are similar: public filings first, third-party aggregators second, property records third.
FAQ
Is the $9 million estimate for Frank D'Amelio based on assets only, or net worth after taxes and liabilities?
It depends on which definition you use. The article’s range ($7 million to $12 million) is meant to reflect disclosed equity plus reasonable assumptions for taxes and liquidity, but true net worth can move if you include or exclude things like vested but unsold shares, spousal assets, trust holdings, or leverage from mortgages you would only see in some county/property records.
How should I interpret a recent Form 4 RSU grant if I’m trying to estimate net worth from stock holdings?
You can sanity-check the valuation by pairing equity disclosures (Forms 4) with the typical RSU lifecycle. If a cliff vesting event occurs, the shares can be sold shortly after due to tax withholding, so a still-large “paper value” in RSUs may translate to a smaller realized value than expected.
What’s the biggest mistake people make when converting SEC equity disclosures into a net worth number?
If the Form 4 shows restricted shares or RSUs that have not vested, they should not be treated as fully liquid. Use vesting dates and transaction codes to separate “granted” from “vested and owned,” then adjust for likely withholding taxes (often handled by net share settlement).
What if I see a different “Frank D’Amelio” in search results, could it be the same person?
Yes, but the article’s evidence checklist style means you should still be consistent. Always verify the exact middle initial and corporate roles, then confirm with the same employer context appearing in filings. Name confusion is common when multiple “Frank D’Amelio” entries exist across different databases.
Why can third-party net worth sites disagree with the latest SEC filing timing?
You should expect a lag. Annual or semiannual reporting can miss intra-year movements, and some insider transactions are reported only after certain thresholds or timing windows. That means a single aggregator snapshot can be stale compared with the latest filing you can pull directly from the SEC.
What assumptions most affect the size of the $7 million to $12 million range?
The article cites equity compounding and board/advisory roles as major drivers. A different tax residence, different capital gains rate assumptions, or different modeling for cost basis can swing the modeled valuation even when the underlying holdings are correct, which is why ranges are usually wider than the point estimate.
How much does adding another board seat realistically change net worth estimates for executives like this?
Board seat additions are plausible upside, but the size of the jump depends on whether the new role comes with material equity grants versus mostly cash-only compensation. If you’re doing your own update, check whether new compensation is in RSUs, options, or deferred compensation, since those behave very differently in valuation.
What downside scenario should I watch for beyond “the market went down”?
A sharp drop is less likely without clear evidence, but you can still model downside by looking at concentrated equity risk. If a large portion of net worth is tied to HPE or Pfizer-related holdings, a downturn plus tax-driven selling around vesting can reduce net value faster than someone expects.
How should I treat private investments and real estate in executive net worth estimates when there is no clear public disclosure?
Yes, because “net worth” aggregators often mix estimates of retirement accounts, private assets, and sometimes real estate. The article emphasizes the disclosure gap for those categories, so if you cannot verify private holdings, treat any “final number” from an aggregator as a hypothesis, not a fact.
